MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Omalizumab Weight-Based Dosing Efficacy Trial
Phase 2
Not yet recruiting
- Conditions
- AllergiesFood Allergy
- Interventions
- Drug: 5mg/kg omalizumab injectionDrug: 15mg/kg omalizumab injection
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06943534
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸University of Texas Southwestern, Dallas, Texas, United States
Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)
Phase 1
Not yet recruiting
- Conditions
- Neurofibromatosis 1 (NF1)Neurofibromatosis Type I
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT06934928
- Locations
- 🇺🇸
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, United States
A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences
Not Applicable
Recruiting
- Conditions
- Psychotic DisordersMood DisordersAnxiety Disorders
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 192
- Registration Number
- NCT06929442
- Locations
- 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States
Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap
Phase 2
Not yet recruiting
- Conditions
- NeuromaNeuropathic Pain
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06915662
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Not Applicable
Not yet recruiting
- Conditions
- Bone Marrow Transplant ComplicationsGraft-versus-Host Disease
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 350
- Registration Number
- NCT06910969
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT
Not Applicable
Not yet recruiting
- Conditions
- Lung CancerHealth ScreeningEarly Cancer DetectionDeep Learning
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 1500
- Registration Number
- NCT06910956
The BEACON Trial: Diagnostic Tools for Breast Lymphedema After Treatment for Breast Cancer
Not yet recruiting
- Conditions
- Breast EdemaBreast LymphedemaLymphedema, Breast CancerLymphedema
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06900023
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Mindfulness-based Neurofeedback to Reduce Negative Thinking in CHARMS Adolescents
Not Applicable
Not yet recruiting
- Conditions
- Repetitive Negative ThinkingSerious Mental Illness Symptoms
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT06901232
- Locations
- 🇺🇸
Massachusetts General Hospital, Center for Addiction Medicine, 101 Merrimac Street, Suite 320, Boston, MA 02114, Boston, Massachusetts, United States
Metabolism Enhancement by Laser Therapy
Not Applicable
Not yet recruiting
- Conditions
- Metabolism Disorder
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT06899958
- Locations
- 🇺🇸
MGH Clinical Unit for Research Trials & Outcomes in Skin, Boston, Massachusetts, United States
Development and Testing of a Mobile App to Scale Delivery of Cognitive-behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
Not Applicable
Not yet recruiting
- Conditions
- Avoidant/Restrictive Food Intake Disorder (ARFID)
- First Posted Date
- 2025-03-27
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06898177
© Copyright 2025. All Rights Reserved by MedPath